Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 15.62% is 36% above its 5-year average of 11.49%, near the high end of its 5-year range (7.53%–15.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.44% above its 12-month average of 14.54%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 15.62%.
RETURN ON EQUITY (ROE)
15.62%
RETURN ON EQUITY (ROE) AVG TTM
14.54%
RETURN ON EQUITY (ROE) AVG 3Y
12.72%
RETURN ON EQUITY (ROE) AVG 5Y
11.49%
RETURN ON EQUITY (ROE) AVG 10Y
12.73%
RETURN ON EQUITY (ROE) AVG 15Y
10.51%
RETURN ON EQUITY (ROE) AVG 20Y
8.27%
CURRENT VS TTM AVG
+7.44%
CURRENT VS 3Y AVG
+22.83%
CURRENT VS 5Y AVG
+35.96%
CURRENT VS 10Y AVG
+22.70%
CURRENT VS 15Y AVG
+48.71%
CURRENT VS 20Y AVG
+88.84%
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
+138.86%
vs the sector median at left
LeMaitre Vascular, Inc.
Market Cap
$1.82B
Return on Equity (ROE)
15.62%
TTM Avg
14.54%
3Y Avg
12.72%
5Y Avg
11.49%
Market Cap
$1.84B
Return on Equity (ROE)
4.88%
TTM Avg
4.47%
3Y Avg
6.79%
5Y Avg
5.89%
Market Cap
$1.81B
Return on Equity (ROE)
-43.94%
TTM Avg
-43.41%
3Y Avg
-41.23%
5Y Avg
-29.16%
Market Cap
$1.80B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.86B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$1.86B
Return on Equity (ROE)
N/A
TTM Avg
-157.29%
3Y Avg
-33.70%
5Y Avg
49.06%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$1.75B
Return on Equity (ROE)
N/A
TTM Avg
36.48%
3Y Avg
36.48%
5Y Avg
36.48%
Market Cap
$1.73B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.82B | 15.62% | 14.54% | 12.72% | 11.49% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 4.88% | 4.47% | 6.79% | 5.89% |
| Novocure Ltd (NVCR)vs › | $1.81B | -43.94% | -43.41% | -41.23% | -29.16% |
| Absci Corporation (ABSI)vs › | $1.80B | -49.19% | -59.18% | -54.84% | -44.72% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | -40.09% | 4.56% | -13.84% | -2.18% |
| Novavax, Inc. (NVAX)vs › | $1.86B | N/A | -157.29% | -33.70% | 49.06% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.75B | N/A | 36.48% | 36.48% | 36.48% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -40.41% | -45.75% | -30.11% | -18.95% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -54.96% | -60.50% | -51.30% | -42.73% |
ROE
15.6%
ROA
10.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 15.62% |
| 2026-03-31 | 15.35% |
| 2025-12-31 | 14.67% |
| 2025-09-30 | 14.08% |
| 2025-06-30 | 12.99% |
| 2025-03-31 | 12.99% |
| 2024-12-31 | 13.06% |
| 2023-12-31 | 10.11% |
| 2023-09-30 | 9.45% |
| 2023-06-30 | 8.89% |
| 2023-03-31 | 7.53% |
| 2022-12-31 | 7.69% |
| 2022-09-30 | 8.11% |
| 2022-06-30 | 8.62% |
| 2022-03-31 | 10.48% |
| 2021-12-31 | 10.59% |
| 2021-09-30 | 11.15% |
| 2021-06-30 | 15.48% |
| 2021-03-31 | 13.51% |
| 2020-12-31 | 12.30% |
| 2020-09-30 | 11.68% |
| 2020-06-30 | 10.79% |
| 2020-03-31 | 11.82% |
| 2019-12-31 | 12.11% |
| 2019-09-30 | 13.59% |
| 2019-06-30 | 13.43% |
| 2019-03-31 | 16.98% |
| 2018-12-31 | 17.62% |
| 2018-09-30 | 16.91% |
| 2018-06-30 | 18.16% |
| 2018-03-31 | 15.70% |
| 2017-12-31 | 15.65% |
| 2017-09-30 | 14.60% |
| 2017-06-30 | 13.91% |
| 2017-03-31 | 12.71% |
| 2016-12-31 | 12.10% |
| 2016-09-30 | 12.14% |
| 2016-06-30 | 11.33% |
| 2016-03-31 | 10.61% |
| 2015-12-31 | 9.96% |
| 2015-09-30 | 9.63% |
| 2015-06-30 | 8.50% |
| 2015-03-31 | 8.08% |
| 2014-12-31 | 5.74% |
| 2014-09-30 | 4.09% |
| 2014-06-30 | 3.82% |
| 2014-03-31 | 3.93% |
| 2013-12-31 | 5.77% |
| 2013-09-30 | 5.80% |
| 2013-06-30 | 5.72% |
| 2013-03-31 | 5.68% |
| 2012-12-31 | 4.86% |
| 2012-09-30 | 4.28% |
| 2012-06-30 | 5.33% |
| 2012-03-31 | 4.74% |
| 2011-12-31 | 4.11% |
| 2011-09-30 | 7.14% |
| 2011-06-30 | 7.70% |
| 2011-03-31 | 9.67% |
| 2010-12-31 | 11.48% |
| 2010-09-30 | 10.37% |
| 2010-06-30 | 10.34% |
| 2010-03-31 | 9.26% |
| 2009-12-31 | 3.31% |
| 2009-09-30 | 1.35% |
| 2009-06-30 | -1.71% |
| 2009-03-31 | -5.98% |
| 2008-12-31 | -7.24% |
| 2008-09-30 | -10.62% |
| 2008-06-30 | -13.18% |
| 2008-03-31 | -10.43% |
| 2007-12-31 | -6.04% |
| 2007-09-30 | -4.91% |
| 2007-06-30 | -1.69% |
| 2007-03-31 | -4.33% |
| 2006-12-31 | -2.31% |
| 2006-09-30 | -3.99% |
| 2006-06-30 | -6.45% |
| 2006-03-31 | 1.98% |
| 2005-12-31 | 0.30% |
| 2004-12-31 | 6.26% |
